A study comparing IGF2BP3 expression via IHC in 39 cases of invasive breast carcinoma with BRCA mutations and 54 cases of sporadic invasive breast carcinoma revealed that IGF2BP3 expression was more commonly observed in carcinomas with BRCA mutations (12). The gene discussed is IGF2BP3; the disease is carcinoma.